An investigational gene therapy can safely restore the immune systems of infants and children who have a rare, life-threatening inherited immunodeficiency disorder.
NIAID has awarded $10 million in first-year funding to establish a clinical research network called Childhood Asthma in Urban Settings (CAUSE). This nationwide network will conduct observational studies and clinical trials tailored to improve asthma treatments and prevention approaches in children of low-income families.
A new NIA study suggests that short sleep duration during midlife could increase the risk of developing dementia later in life.
In two landmark studies, researchers have used cutting-edge genomic tools to investigate the potential health effects of exposure to ionizing radiation, a known carcinogen, from the 1986 accident at the Chernobyl nuclear power plant in northern Ukraine.
NIH researchers have identified and tested a drug combination that exploits a weakness in small cell lung cancer (SCLC).
NIH researchers recently found that SARS-CoV-2, the virus that causes Covid-19, can infect cells in the mouth.
An NIH research team developed a test to evaluate the expressive language skills of people with Down syndrome, a condition resulting from an extra copy or piece of chromosome 21.
African Americans who smoke appear to have more than twice the risk of developing coronary heart disease compared to non-smokers.
NIH will expand and strengthen commitments to respectfully engage American Indian and Alaska Native (AI/AN) people and support their inclusion in the All of Us Research Program.
Scientists have genetically engineered immune cells, called myeloid cells, to precisely deliver an anticancer signal to organs where cancer may spread.